Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD-TB
PACTR202404734179820Phase 2Not yet recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pulmonary tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Planned start Apr 2024; status: not yet recruiting.
02
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202404734179820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404734179820.